Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 20/12/21 → 19/12/26 |
Keywords
- Randomised clinical trial
- treatment safety
- treatment efficacy
- asthma
Clinical Trial Phase
- Phase III (a & b)
NIMBLE Study - A 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294 compared with mepolizumab or benralizumab
- Bardin, Philip (Primary Chief Investigator (PCI))
Project: Research